The Clinical Trials Network (CTNx) Revenue and Competitors
Estimated Revenue & Valuation
- The Clinical Trials Network (CTNx)'s estimated annual revenue is currently $1.9M per year.
- The Clinical Trials Network (CTNx)'s estimated revenue per employee is $77,112
Employee Data
- The Clinical Trials Network (CTNx) has 25 Employees.
- The Clinical Trials Network (CTNx) grew their employee count by 32% last year.
The Clinical Trials Network (CTNx)'s People
Name | Title | Email/Phone |
---|
The Clinical Trials Network (CTNx) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $53.2M | 417 | 3% | N/A | N/A |
#2 | $9.1M | 89 | 10% | N/A | N/A |
#3 | $28.3M | 252 | 0% | N/A | N/A |
#4 | $2.1M | 29 | -6% | N/A | N/A |
#5 | $1.1M | 18 | -5% | N/A | N/A |
#6 | $6.4M | 70 | N/A | N/A | N/A |
#7 | $10.1M | 99 | 6% | N/A | N/A |
#8 | $8.3M | 81 | 11% | N/A | N/A |
#9 | $2.7M | 33 | 0% | N/A | N/A |
#10 | $5.7M | 62 | 13% | N/A | N/A |
What Is The Clinical Trials Network (CTNx)?
What is CTNx?\n\n• The Clinical Trials Network (CTNx) is a network of more than 75 clinical research sites. \n\nWe work with:\n\n1) Experienced Research Sites - we've helped numerous existing research sites optimize their research efforts improving efficiency, productivity, and ROI.\n\n2) New Research Sites - one of our specialties is helping new research sites get up and running quickly. CTNx is well-known for our industry-leading 3-step training program and site on-boarding process.\n\nCTNx Networks:\n- Gastroenterology\n- Neurology\n- Ophthalmology\n- Dermatology\n- Allergy & Immunology
keywords:N/AN/A
Total Funding
25
Number of Employees
$1.9M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 25 | -4% | N/A |
#2 | $2.5M | 25 | 4% | N/A |
#3 | $15M | 25 | -4% | N/A |
#4 | $7.7M | 25 | -17% | N/A |
#5 | $4.7M | 25 | 0% | N/A |